During the menopausal period the declined ovarian function results in a drastic reduction of estrogen hormone secretion which leads to important endocrine, somatic, and psychological changes. During this period, women are bothered by unpleasant symptoms responsible for physical discomforts and lower quality of life.
This interventional clinical study aimed to assess the efficacy of the oral intake of a food supplement containing 200 mg a peculiar sodium hyaluronate (SH) as adjuvant of the radiofrequency (RF) and radioporation (RP) treatment in menopausal women suffering of vulvovaginal atrophy.
PARTICIPANTS & METHOD
30 menopausal women (age between 45 and 65 years old) affected by vaginal dryness associated or not with atrophy were equally and randomly divided in two groups and received the RF/RP treatment (control) or RF/RP treatment plus one capsule/day of the food supplement for eight weeks.
All the enrolled subjects attended a gynecological visit at the recruitment (T0), at the end of the RF/ RP cycle (T5), at the end of dietary supplement intake (T8) and after two months of follow-up (T16). Treatment efficacy was evaluated in terms of vaginal functional wellbeing and persistence of vaginal atrophy symptoms by clinicians at each visit.
Administration of the food supplement resulted in significant amelioration of the clinical conditions with respect to the standard procedure (RF/RP) alone.
FRANCESCO TURSI
LABORATORY DIRECTOR
VINCENZO NOBILE
R&D MANAGER AND COSMETIC MARKET MANAGER
COMPLIFE. COMMITTED TO SCIENCE, COMMITTED TO YOU.
